Ambulatory Blood Pressure Monitoring in Children and Adolescents: 2022 Update: A Scientific Statement from the American Heart Association

Joseph T. Flynn, Elaine M. Urbina, Tammy M. Brady, Carissa Baker-Smith, Stephen R. Daniels, Laura L. Hayman, Mark Mitsnefes, Andrew Tran, Justin P. Zachariah

Research output: Contribution to journalReview articlepeer-review

Abstract

Use of ambulatory blood pressure monitoring in children and adolescents has markedly increased since publication of the last American Heart Association scientific statement on pediatric ambulatory blood pressure monitoring in 2014. In addition, there has also been significant expansion of the evidence base for use of ambulatory blood pressure monitoring in the pediatric population, including new data linking ambulatory blood pressure levels with the development of blood pressure-related target organ damage. Last, additional data have recently been published that enable simplification of the classification of pediatric ambulatory monitoring studies. This scientific statement presents a succinct review of this new evidence, guidance on optimal application of ambulatory blood pressure monitoring in the clinical setting, and an updated classification scheme for the interpretation of ambulatory blood pressure monitoring in children and adolescents. We also highlight areas of uncertainty where additional research is needed.

Original languageEnglish (US)
Pages (from-to)E114-E124
JournalHypertension
Volume79
Issue number7
DOIs
StatePublished - Jul 1 2022

Keywords

  • AHA Scientific Statements
  • adolescent
  • ambulatory
  • blood pressure monitoring
  • child
  • hypertension

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Ambulatory Blood Pressure Monitoring in Children and Adolescents: 2022 Update: A Scientific Statement from the American Heart Association'. Together they form a unique fingerprint.

Cite this